Skip to main content

Closed

LLY: Eli Lilly and Company Stock Analysis | finqOS

Healthcare · Drug Manufacturers - General

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Revenue growth+44.7% / yr

Operating margin45.9%

ROIC32.1%

Financially safe

Strong

Debt / equity1.39×

Interest coverage37.5×

Current ratio1.50×

Valuation

Unrated

P/E ratio40.7×

Dividend yield0.6%

Eli Lilly and Company

LLYNew York Stock Exchange·USD·Closed

Eli Lilly and Company

LLYNew York Stock Exchange·USD·Closed

$1148.50

−0.56%

$1148.50

−$6.47 (0.56%)

52W Range

84thpctl

Volume

0.75×avg

Mkt Cap

1.08TUSD

P/E

40.7TTM

Div Yield

0.56%ann

52W Range

84thpctl

Volume

0.75×avg

Market Cap

1.08TUSD

P/E Ratio

40.7TTM

Div Yield

0.56%ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings